Dr. Paul Steven Yamauchi
Claim this profileClinical Science Institute
Studies Atopic Dermatitis
Studies Eczema
4 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Science Institute
More about Paul Steven Yamauchi
Clinical Trial Related6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Paul Steven Yamauchi has experience with
- Lebrikizumab
- Mirikizumab
- Baricitinib
Breakdown of trials Paul Steven Yamauchi has run
Atopic Dermatitis
Eczema
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Steven Yamauchi specialize in?
Paul Steven Yamauchi focuses on Atopic Dermatitis and Eczema. In particular, much of their work with Atopic Dermatitis has involved treating patients, or patients who are undergoing treatment.
Is Paul Steven Yamauchi currently recruiting for clinical trials?
No, Paul Steven Yamauchi is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Paul Steven Yamauchi has studied deeply?
Yes, Paul Steven Yamauchi has studied treatments such as Lebrikizumab, Mirikizumab, Baricitinib.
What is the best way to schedule an appointment with Paul Steven Yamauchi?
Apply for one of the trials that Paul Steven Yamauchi is conducting.
What is the office address of Paul Steven Yamauchi?
The office of Paul Steven Yamauchi is located at: Clinical Science Institute, Santa Monica, California 90404 United States. This is the address for their practice at the Clinical Science Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.